Skip to content
Search

Latest Stories

PharmaOutcomes, SystmOne launch new electronic notifications service for vaccinations

Two system suppliers, PharmaOutcomes and SystmOne, have rolled out a new service which enables information about flu vaccinations to be sent electronically from pharmacies to GP practices, NHS Digital announced today.

Th roll out follows a successful pilot that took place in Leeds in October involving 113 community pharmacies and 83 GP practices. During the two-week pilot, 2,500 messages were electronically transferred.


The service was then expanded across England for pharmacies and GPs using PharmaOutcomes and SystmOne over the following two months.

So far, over 30,000 electronic messages carrying flu vaccine information have been sent during this winter’s flu season. According to NHS Digital, this has saved time for GP practices and pharmacies, helped to improve data quality and reduced the possibility of errors.

The system also prevents patients who have already had a flu vaccine from being contacted unnecessarily and could be used to identify those in at-risk groups who haven’t had their vaccine.

Vishen Ramkisson, a GP and senior clinical lead at NHS Digital, said: “This is a valuable enhancement which helps ensure the information in patients’ medical records is comprehensive and up to date. Services which make it easier for health professionals to share critical information, such as about whether a vaccination has been given, enable them to provide the best care possible to patients.”

Other suppliers are expected to start their roll out later this year, following similar pilot schemes.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less